-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Australian Penny Stocks With Strong Financial Health Worth A Closer Look

Simply Wall St·07/27/2026 04:41:58
语音播报

Penny stocks often sit at the crossroads of risk and potential reward, and in a world where energy shocks, shifting interest rate paths and uneven inflation keep investors guessing, financial strength can matter more than excitement. The Financially Fit Penny Stocks screener focuses on companies trading below 5 that still show healthier balance sheets than many early stage peers. That combination can help you look beyond the headlines and focus on businesses with firmer footing. In this article, you will see 3 of the notable stocks from this screener that stand out on financial health, not hype.

DroneShield (ASX:DRO)

Overview: DroneShield (ASX:DRO) develops and sells counter drone hardware and software that detect, track and disrupt hostile drones for defence forces, critical infrastructure operators and public venue security across multiple regions, including Australia, the US and Europe.

Operations: DroneShield generates all of its A$216.8 million revenue from Aerospace & Defense, with A$194.99 million attributed to Australia and the rest of the world and A$29.73 million to the USA, partly offset by A$8.17 million of eliminations.

Market Cap: A$1.89b

DroneShield sits at the intersection of fast growing demand for counter drone defence and the shift from one off deals to repeat institutional contracts, particularly across NATO and US channels. The stock has recently moved from loss making to profitable, with earnings growth rates above 50% a year and forecasts pointing to strong revenue gains. Its P/S is roughly in line with higher growth peers. At the same time, investors need to weigh real risks such as reliance on external borrowing, an inexperienced board and management team, and an ASIC investigation into past disclosures. For readers who want to understand whether these governance and funding questions outweigh the appeal of high quality earnings and a deepening order book, the full story matters.

DroneShield’s shift to profitability and institutional contracts is catching attention, but the real story sits in how growth expectations stack up against its funding and governance questions. Get the analyst forecasts for DroneShield and see what the forecasts might be missing.

ASX:DRO Earnings & Revenue Growth as at Jul 2026
ASX:DRO Earnings & Revenue Growth as at Jul 2026

Sigma Healthcare (ASX:SIG)

Overview: Sigma Healthcare (ASX:SIG) runs one of Australia’s large pharmacy wholesale and franchising networks, supplying medicines and health products to community pharmacies while supporting branded retail chains such as Chemist Warehouse, Amcal and Discount Drug Stores, alongside online sales and logistics services for drug manufacturers.

Operations: Sigma Healthcare generates A$9.55b in revenue from Healthcare activities, with A$9.16b from Australia and A$389.79m from international customers.

Market Cap: A$32.67b

Sigma Healthcare can interest investors who want exposure to a large scale pharmacy distributor with earnings growth forecasts of 15% a year and revenue growth expectations above the broader Australian market, yet with some clear tension points. The company is priced on a rich P/E multiple and net margins have moved from 11.5% to 6.3%, which raises questions about how much of that growth is already reflected in the valuation. At the same time, high quality earnings sit alongside funding risk from reliance on external borrowing and a relatively inexperienced board and management team. For readers weighing growth against governance and balance sheet questions, there is more under the surface than the headline figures suggest.

Accelerating growth forecasts and a rich P/E put Sigma Healthcare at the center of a tug of war between optimism and doubt, so get the full story in the analyst forecasts for Sigma Healthcare and see what the margin pressure might really be signaling.

ASX:SIG P/E Ratio as at Jul 2026
ASX:SIG P/E Ratio as at Jul 2026

Stanmore Resources (ASX:SMR)

Overview: Stanmore Resources (ASX:SMR) is a Brisbane based miner focused on exploring, developing and producing metallurgical coal from a large portfolio of tenements in Queensland's Bowen and Surat basins, supplying steelmakers across key global markets.

Operations: Stanmore Resources generates A$1.88b in revenue from producing and selling metallurgical and thermal coal, primarily to customers in Asia, Europe and South America.

Market Cap: A$2.57b

Stanmore Resources stands out in this penny stock screener because it pairs a substantial A$1.88b coal business with the potential for margin improvement as cost efficiencies, automation and past capital investments start to feed through to earnings. Analysts expect earnings to move from a loss toward A$109.4 million by 2029 and see room for improved return on equity, yet revenue is expected to edge down and the company is still unprofitable today, with all liabilities funded by external borrowing. In addition, there is exposure to metallurgical coal prices, Queensland weather risks and evolving climate policy, so investors who only look at the headline valuation or dividend could miss some important moving parts in Stanmore Resources' story.

Stanmore Resources has a sizable A$1.88b coal business, yet the real tension is how a still unprofitable operation might shift if earnings move toward A$109.4 million. Get the analyst forecasts for Stanmore Resources and see whether those projections are masking a bigger twist in the story

ASX:SMR Earnings & Revenue Growth as at Jul 2026
ASX:SMR Earnings & Revenue Growth as at Jul 2026

The three stocks covered here are just a starting point. The full screener surfaces 404 more companies in the Financially Fit Penny Stocks screener that each carry their own financial story and potential catalysts. Use Simply Wall St to unlock filters around balance sheet strength, funding risks and earnings drivers so you can identify and analyze the highest conviction penny stock opportunities for your watchlist.

Take Control of Your Investment Journey

If DroneShield or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Beyond Today’s Ideas?

Fresh opportunities do not stay under the radar for long, and the next breakout stocks can start moving before the crowd catches on. Review these ideas and consider whether they belong on your watchlist.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.